Article
Breast cancer risk and germline genomic profiling of women with neurofibromatosis type 1 who developed breast cancer.
Genes, chromosomes & cancer - 1 Jan 2018
Wang Xia, Teer Jamie K, Tousignant Renee N, Levin Albert M, Boulware David, Chitale Dhananjay A, Shaw Brandon M, Chen Zhihua, Zhang Yonghong, Blakeley Jaishri O, Acosta Maria T, Messiaen Ludwine M, Korf Bruce R, Tainsky Michael A
Abstract excerpt
NF1 mutations predispose to neurofibromatosis type 1 (NF1) and women with NF1 have a moderately elevated risk for breast cancer, especially under age 50. Germline genomic analysis may better define the risk so screening and prevention can be applied to the individuals who benefit the most. Survey conducted in several neurofibromatosis clinics in the United States has demonstrated a 17.2% lifetime risk of breast...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
